| Page 13 | Cafepharma

You are here

Primary tabs

Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma

Post date: May 10, 2018 - 10:58pm

DNAtix Releases its First Open Source DNA Compression Tool

Post date: May 10, 2018 - 1:14pm

Lilly Acquires Immuno-Oncology Asset With $1.6 Billion Purchase of ARMO BioSciences

Post date: May 10, 2018 - 10:17am

Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer

Post date: May 10, 2018 - 9:52am

Knopp Biosciences' Dexpramipexole Meets Primary Endpoints in Phase 2 Trial Results in Hypereosinophilic Syndromes (HES)

Post date: May 10, 2018 - 9:31am

Novartis Actually Paid Michael Cohen $1.2 Million – For Nothing

Post date: May 9, 2018 - 2:24pm

Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer

Post date: May 9, 2018 - 9:42am

HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead

Post date: May 9, 2018 - 9:22am

Novartis Paid $400,000 to Trump's Atty Michael Cohen According to Stormy Daniels' Lawyer

Post date: May 8, 2018 - 8:37pm

Faron Pharmaceuticals Drug Traumakine Fails Ph III Trial

Post date: May 8, 2018 - 3:45pm

Pages